SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLTR COULTER PHARMACEUTICAL -- Ignore unavailable to you. Want to Upgrade?

To: Bob L who wrote (558)4/26/2000 4:43:00 PM
From: Hawkmoon  Read Replies (2) | Respond to of 666
 
If Bexxar is the drug that comes in powder form that must be kept refrigerated at minus 40 degrees, then I suspect CLTR will have some very positive surprises after phase 3 trials are finished.

Rumour has it that a particular drug with the above mentioned storage requirements has been found VERY efficacious with NHL.

That rumour is the reason that I bookmarked this threaad to watch the discussion.

Regards,

Ron


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News